Stem cell bioengineered skin
This article was originally published in The Gray Sheet
Executive Summary
U.S. BioDefense, Inc. files for Small Business Innovation Research Grant to support development of its stem-cell technology for the creation of skin grafts to treat skin wounds. The company is focused on the treatment of vesicant-agent-induced cutaneous burns that would result from a mustard gas or other biological weapon attack. The City of Industry, Calif.-based firm is taking advantage of California Proposition 71, which approved an unprecedented $3 bil. investment in stem-cell research funding over the next decade. Wisconsin also is looking to fund stem cell research (1"The Gray Sheet" Nov. 29, 2004, p. 13)...
You may also be interested in...
Wisconsin R&D Windfall Bids To Make Entrepreneurs Of Academics
Medical technology researchers on the University of Wisconsin-Madison faculty will be encouraged to commercialize their findings under a state government initiative costing roughly $750 mil
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.